Transitions: Comings and Goings, Appointments and Promotions
Brigham and Women's Faulkner Hospital
Peggy Duggan, MD
Margaret(Peggy) Duggan, MD, has accepted the position of chief medical officer (CMO) at Brigham and Women's Faulkner Hospital, effective June 1, 2013.
As CMO, Duggan will serve as an advocate for and liaison to the medical staff to ensure that all clinicians have the necessary resources to provide the highest level of patient care. She will be a critical partner with senior hospital administration and department chiefs in guiding ongoing clinical and operational improvement efforts, and in implementing key strategic initiatives. Duggan brings a depth of experience and medical expertise which will help guide her in such areas as patient safety and clinical outcomes, infection control, risk management, regulatory compliance, utilization review, patient-family centered care, clinical informatics, clinical program development, and external physician and network relations.
Duggan completed her undergraduate work at Boston University before obtaining her doctor of medicine at Boston University School of Medicine. She completed her medical residency at Boston Medical Center.
For the past 14 years, she has been an integral part of Brigham and Women's Faulkner Breast Centre, where she has served as medical director since 2002. She has also been on staff at Dana-Farber Cancer Institute since 2004 and is an assistant professor of Surgery at Harvard Medical School.
She demonstrated exceptional leadership, passion, and commitment to Brigham and Women's Faulkner Hospital during her tenure as president of the medical staff from 2009 to 2012. We look forward to that same level of enthusiasm and energy in her new role as CMO.
Duggan will continue to serve as medical director of Brigham and Women's Faulkner Breast Centre, as well as see patients.
BWH Pulmonary Division
|Souheil El-Chemaly, MD, MPH|
Souheil El-Chemaly, MD, MPH, of BWH’s Pulmonary Division, was named clinical director of BWH’s Center for LAM Research and Clinical Care in February.
The LAM center is focused on providing excellence in clinical care and offering access to the most up-to-date clinical trials for patients with lymphangioleiomyomatosis (LAM), a rare lung disease affecting only women, primarily of child-bearing age.
“Since LAM is a multisystem disease affecting the lungs, kidneys and brain, we work to provide the best possible care in a multidisciplinary fashion,” said El-Chemaly. “It is a privilege to be able to work with these courageous patients in a clinical setting and learn more about the disease through research.”
Before joining BWH two years ago, El-Chemaly completed post-doctorate fellowships in pulmonary and critical care at the National Institutes of Health (NIH) and the University of Miami. He received his MD from Saint Joseph’s University and his MPH from American University, both in Beirut, Lebanon. El-Chemaly completed his residency in internal medicine at St. Luke’s-Roosevelt Hospital Center, a teaching affiliate of Columbia University College of Physicians & Surgeons. El-Chemaly’s research interest is lymphatics in lung disease. During his time at the NIH, he worked with one of the largest registries of LAM patients in the world.